NCT03088059 2023-11-03UPSTREAMEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Unknown340 enrolled
NCT02643550 2023-05-12Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckInnate PharmaPhase 1/2 Completed143 enrolled